SLXN

Silexion Therapeutics
SLXN

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $258K invested in Silexion Therapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less capital invested

Capital invested by funds: $ → $
Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.5K
2
+$16.2K
3
+$12K
4
SG
StoneX Group
New York
+$9.11K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
1
Wildcat Capital Management
New York
$91.9K
UBS Group
2
UBS Group
Switzerland
$88.5K
MHC
3
Meyer Handelman Company
New York
$26.7K
MSAM
4
Moloney Securities Asset Management
Missouri
$16.2K
SS
5
SBI Securities
Japan
$13.3K
VF
6
Virtu Financial
New York
$12K
SG
7
StoneX Group
New York
$9.11K
Bank of America
8
Bank of America
North Carolina
$405